Drug delivery describes the method and approach to delivering drugs or pharmaceuticals to their site of action within an organism. The main goal of drug delivery is to achieve a therapeutic outcome. The issues of pharmacodynamics and pharmacokinetics are the important considerations for drug delivery.

South America Drug Delivery Devices Market Report Segments Size & Growth:

South America drug delivery devices market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include technological advancements, increased prevalence of chronic diseases, need for controlled drug release, the rise in individual therapy, and increased understanding about drug metabolism among the population. However, recall of the products, strict regulatory framework, and injuries and infections fear while usage is thereby hindering the market growth. Various opportunities for drug delivery devices market include increasing demand for biosimilars and generic drugs, focus on overcoming unmet medical needs, self-administration & home care, and emerging markets.

South America Drug Delivery Devices Market Report Segments Share:

South America drug delivery devices market is categorised into the mode of delivery which comprises of nasal, oral, ocular, implantable, injectable, transdermal, topical, pulmonary, rectal, and other. Furthermore, they are categorised into various sub-segments. By nasal, it is segmented into nasal inhalers, nasal sprays, nasal drops, and others. By oral, it is segmented into hydrodynamic pressure controlled system, slow dissolving salts & complexes, ion – exchange resin drug complexes, Ph – independent formulations, osmotic pressure controlled systems, diffusion controlled systems, and dissolution controlled systems. By ocular, it is segmented into ointments & gels, eye drops, and others. By implantable, it is segmented into intravitreal implants, brachytherapy seeds, contraceptives, and drug-eluting stents. By injectable, it is segmented into conventional drug delivery and self-Injected drug delivery.

By transdermal, it is segmented into the mode of administration, type of patches, & transdermal gels and they are further segmented into microscopic injections, ultrasound, electroporation, iontophoresis, vapour patch, matrix, reservoir, multilayer drug in adhesive, single layer drug in the adhesive. By topical, it is segmented into semi-solid formulations, liquid formulations, and solid formulations. By pulmonary, it is segmented into the nebuliser, dry powder inhalers, and metered dose inhalers. The topical segment is anticipated to witness the highest growth rate. The factors which the boosting the growth of the segment are convenience and ease of use, ease of dosage, painlessness, noninvasiveness, and enhanced patient compliance.

By end-users, the market is segmented into hospitals, ambulatory surgical centres or clinics, home care settings, diagnostic centres, and others. Among them, the hospital’s segment is expected to hold the largest share in the market during the forecast period owing to increasing number of inpatient and outpatient visits in hospitals when compared to others and the requirement of large volumes of drugs and their respective delivery devices to procure to the demand of the patient pool.

By Geography, Brazil is expected to hold the largest share in the market because of the increasing demand for improved drug delivery systems, rising accessibility and affordability of drug delivery devices, and increasing number of chronic diseases in the region. Argentina is expected to witness the highest growth rate because of rising prevalence of various chronic diseases and ageing population in this region. Furthermore, the improving economic conditions in the region are also expected to support the growth of the drug delivery devices market in South-America.

South America Drug Delivery Devices Market Report Trends:

• Baxter International Inc., a global leader in sterile medication production and delivery, announced that the U.S. Food and Drug Administration approved the medication used in a common nonsurgical procedure to treat blocked or narrowed blood vessels in the heart.
• Smith medical company has launched a new product called CADD-solis VIP ambulatory infusion pump, reliable pump performance, accurate medication delivery and ease of use.

South America Drug Delivery Devices Market Report Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major market players, such as

• Abbott Laboratories
• Braun Melsungen AG
• Pfizer, Inc.
• Hoffmann-La Roche Ltd.
• Baxter International Inc.

Along with these companies, there were many other companies considered/cited in the report while analysing the South America drug delivery devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.